PRE-BUDGET CONSULTATIONS; ORGAN AND TISSUE DONATION; TOBACCO CONTROL (CPP INVESTMENT BOARD TOBACCO HOLDINGS; NATIONAL TOBACCO CONTROL PROGRAMS); NATIONAL DRUG STRATEGY; CROSS-BORDER PHARMACY; INTERNET PHARMACY; FINANCIAL AND TAXATION ISSUES (INCLUDING GST AND PHYSICIAN SERVICES, RRSP LIMITS, PENSION REGULATIONS, RETIREMENT INCOME ISSUES); PRIVACY PROTECTION OF HEALTH INFORMATION AND THE PIPEDA REVIEW.
Politique ou programme
TIMELY ACCESS TO HEALTH CARE; WAIT TIMES AND BENCHMARKS; SUSTAINABILITY OF HEALTH CARE (FINANCING AND ACCESSIBILITY); PRIMARY HEALTH CARE RENEWAL; HEALTH PROMOTION AND DISEASE PREVENTION; HEALTHY LIVING INITIATIVES; PHARMACEUTICAL STRATEGY (INCLUDING MONITORING AND SURVEILLANCE SYSTEMS; MANDATORY REPORTING OF ADVERSE DRUG EFFECTS; TELEHEALTH; PAN-CANADIAN HEALTH HUMAN RESOURCE STRATEGY (INTERNATIONAL MEDICAL GRADUATES); CANADA CORP AND INTERNATIONAL MEDICAL SERVICE INITIATIVES, MEDICAL EDUCATION; TUITION LEVELS AND STUDENT DEBT LOADS (FEDERAL STUDENT LOANS); EMERGENCY PREPAREDNESS, CHILD HEALTH, FEDERAL HEALTH PROGRAMS AND FEDERAL FORMS; NATIONAL HEALTH GOALS; HEALTH INFORMATION TECHNOLOGIES, (ELECTRONIC MEDICAL AND HEALTH RECORDS); MENTAL HEALTH AND NATIONAL STRATEGY; ENVIRONMENT AND HEALTH ISSUES; AND ABORIGINAL HEALTH ISSUES.